Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	2486.74	13703.16	529.75
Graham Fair Price	-9.69	16.16	17.90
PEG	74.21	-0.30	-1.16
Price/Book	-23.38	1.68	2.19
Price/Cash Flow	-7.24	108.01	116.44
Prices/Earnings	< 0.005	53.45	-53.45
Price/Sales	-22.41	21.05	27.13
Price/FCF	-7.24	108.01	116.44
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-4.04	0.78	0.82
Operating Margin	62.82	-0.08	-0.21
ROA	-14.83	< 0.005	< 0.005
ROE	-0.01	< 0.005	-23.38
ROIC	-0.01	< 0.005	59.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.37	< 0.005	-129028.50
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.19	0.62	220.01
EPS QOQ	-0.46	1.79	287.72
FCF QOQ	0.56	-0.15	-72.86
Revenue QOQ	0.04	0.01	-67.87
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5635.60	< 0.005	-100.00
Days Sales Outstanding (DSO)	153.62	187.16	21.83
Inventory Turnover	0.02	69867000.00	437491267257.01
Debt/Capitalization	0.33	0.22	-32.44
Quick Ratio	0.75	0.68	-9.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	37.31	38.49	3.17
Cash	24.10	18.42	-23.54
Capex	-0.05	-0.04	29.30
Free Cash Flow	0.70	0.60	-14.78
Revenue	3.01	3.06	1.88
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.69	1.63	-3.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.56	209.86	972.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating